Marlen Haderlein

1.5k total citations
45 papers, 702 citations indexed

About

Marlen Haderlein is a scholar working on Oncology, Surgery and Otorhinolaryngology. According to data from OpenAlex, Marlen Haderlein has authored 45 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 18 papers in Surgery and 18 papers in Otorhinolaryngology. Recurrent topics in Marlen Haderlein's work include Head and Neck Cancer Studies (18 papers), Salivary Gland Tumors Diagnosis and Treatment (10 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Marlen Haderlein is often cited by papers focused on Head and Neck Cancer Studies (18 papers), Salivary Gland Tumors Diagnosis and Treatment (10 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Marlen Haderlein collaborates with scholars based in Germany, China and Austria. Marlen Haderlein's co-authors include Rainer Fietkau, Markus Hecht, Luitpold Distel, Sabine Semrau, Arndt Hartmann, Maike Büttner‐Herold, Sebastian Lettmaier, Heinrich Iro, Rainer Fietkau and Katharina Erlenbach‐Wünsch and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Marlen Haderlein

43 papers receiving 699 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marlen Haderlein Germany	15	415	245	133	127	116	45	702
X. Liem France	13	278 0.7×	129 0.5×	273 2.1×	266 2.1×	421 3.6×	51	854
Bruno Fionda Italy	18	317 0.8×	234 1.0×	97 0.7×	212 1.7×	221 1.9×	104	840
Jennifer Shah United States	12	161 0.4×	178 0.7×	280 2.1×	169 1.3×	173 1.5×	48	557
Igor Sirák Czechia	15	191 0.5×	263 1.1×	89 0.7×	204 1.6×	165 1.4×	74	699
É. Chajon France	16	153 0.4×	144 0.6×	220 1.7×	441 3.5×	482 4.2×	56	947
Brandon A. Dyer United States	14	146 0.4×	93 0.4×	41 0.3×	161 1.3×	301 2.6×	45	626
Amy Chang China	15	292 0.7×	297 1.2×	435 3.3×	457 3.6×	191 1.6×	28	940
Anne Kathrin Höhn Germany	16	142 0.3×	175 0.7×	70 0.5×	138 1.1×	382 3.3×	69	862
Ken Kudura Switzerland	14	163 0.4×	88 0.4×	32 0.2×	156 1.2×	340 2.9×	40	592
Runye Wu China	12	213 0.5×	100 0.4×	90 0.7×	88 0.7×	78 0.7×	45	399

Countries citing papers authored by Marlen Haderlein

Since Specialization

Citations

This map shows the geographic impact of Marlen Haderlein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marlen Haderlein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marlen Haderlein more than expected).

Fields of papers citing papers by Marlen Haderlein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marlen Haderlein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marlen Haderlein. The network helps show where Marlen Haderlein may publish in the future.

Co-authorship network of co-authors of Marlen Haderlein

This figure shows the co-authorship network connecting the top 25 collaborators of Marlen Haderlein. A scholar is included among the top collaborators of Marlen Haderlein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marlen Haderlein. Marlen Haderlein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Haderlein, Marlen, Christopher R. Frei, Thomas Weißmann, et al.. (2025). Is less more? Revisiting elective nodal irradiation in head and neck cancer. Strahlentherapie und Onkologie. 201(11). 1191–1207.

Putz, Florian, Marlen Haderlein, Sebastian Lettmaier, et al.. (2024). Exploring the Capabilities and Limitations of Large Language Models for Radiation Oncology Decision Support. International Journal of Radiation Oncology*Biology*Physics. 118(4). 900–904. 7 indexed citations

Weißmann, Thomas, Michael Rückert, Florian Putz, et al.. (2023). Low-dose radiotherapy of osteoarthritis: from biological findings to clinical effects—challenges for future studies. Strahlentherapie und Onkologie. 199(12). 1164–1172. 11 indexed citations

Werner, René, Frederic Madesta, Thilo Sentker, et al.. (2023). Clinical application of breathing-adapted 4D CT: image quality comparison to conventional 4D CT. Strahlentherapie und Onkologie. 199(7). 686–691. 9 indexed citations

Huang, Yixing, Ahmed M. Gomaa, Sabine Semrau, et al.. (2023). Benchmarking ChatGPT-4 on a radiation oncology in-training exam and Red Journal Gray Zone cases: potentials and challenges for ai-assisted medical education and decision making in radiation oncology. Frontiers in Oncology. 13. 1265024–1265024. 76 indexed citations

Beck, Michael, Sabine Semrau, Marlen Haderlein, et al.. (2022). Differences and Similarities in the Pattern of Early Metabolic and Morphologic Response after Induction Chemo-Immunotherapy versus Induction Chemotherapy Alone in Locally Advanced Squamous Cell Head and Neck Cancer. Cancers. 14(19). 4811–4811. 2 indexed citations

Mueller, Sarina K., Marlen Haderlein, Sebastian Lettmaier, et al.. (2022). Targeted Therapy, Chemotherapy, Immunotherapy and Novel Treatment Options for Different Subtypes of Salivary Gland Cancer. Journal of Clinical Medicine. 11(3). 720–720. 31 indexed citations

Weißmann, Thomas, Florian Putz, Sebastian Lettmaier, et al.. (2021). Reduction of Elective Radiotherapy Treatment Volume in Definitive Treatment of Locally Advanced Head and Neck Cancer—Comparison of a Prospective Trial with a Revised Simulated Contouring Approach. Journal of Clinical Medicine. 10(20). 4653–4653. 1 indexed citations

Hecht, Markus, Manfred Schmidt, Marlen Haderlein, et al.. (2021). Influence of Gender on Radiosensitivity during Radiochemotherapy of Advanced Rectal Cancer. Cancers. 14(1). 148–148. 14 indexed citations

10.

Lettmaier, Sebastian, Sabine Semrau, Markus Hecht, et al.. (2021). High-grade salivary gland cancer: is surgery followed by radiotherapy an adequate treatment to reach tumor control? Results from a tertiary referral centre focussing on incidence and management of distant metastases. European Archives of Oto-Rhino-Laryngology. 279(5). 2553–2563. 12 indexed citations

11.

Schubert, Philipp, Sandra Rutzner, Markus Eckstein, et al.. (2021). Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors. BMC Cancer. 21(1). 314–314. 10 indexed citations

12.

Haderlein, Marlen, Oliver J. Ott, Sebastian Lettmaier, et al.. (2020). Dose Reduction to the Swallowing Apparatus and the Salivary Glands by De-Intensification of Postoperative Radiotherapy in Patients with Head and Neck Cancer: First (Treatment Planning) Results of the Prospective Multicenter DIREKHT Trial. Cancers. 12(3). 538–538. 5 indexed citations

13.

Schubert, Philipp, Sandra Rutzner, Markus Eckstein, et al.. (2020). Prospective evaluation of the prognostic value of immune-related adverse events in patients with non-melanoma solid tumour treated with PD-1/PD-L1 inhibitors alone and in combination with radiotherapy. European Journal of Cancer. 140. 55–62. 25 indexed citations

14.

Lettmaier, Sebastian, Markus Hecht, Sabine Semrau, et al.. (2019). Is there a patient population with squamous cell carcinoma of the head and neck region who might benefit from de-intensification of postoperative radiotherapy?. Strahlentherapie und Onkologie. 195(6). 482–495. 7 indexed citations

15.

Semrau, Sabine, Daniela Schmidt, Markus Hecht, et al.. (2019). Classification of three prognostically different groups of head and neck cancer patients based on their metabolic response to induction chemotherapy (IC-1). Oral Oncology. 100. 104479–104479. 4 indexed citations

16.

Haderlein, Marlen, et al.. (2019). Is in vivo and ex vivo irradiation equally reliable for individual Radiosensitivity testing by three colour fluorescence in situ hybridization?. Radiation Oncology. 15(1). 2–2. 9 indexed citations

17.

Haderlein, Marlen, Claudia Scherl, Sabine Semrau, et al.. (2017). Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma. Strahlentherapie und Onkologie. 193(11). 961–970. 24 indexed citations

18.

Haderlein, Marlen, et al.. (2016). Ex Vivo Apoptosis in CD8+ Lymphocytes Predicts Rectal Cancer Patient Outcome. Gastroenterology Research and Practice. 2016. 1–7. 6 indexed citations

19.

Haderlein, Marlen, et al.. (2015). Lipiodol injections for optimization of target volume delineation in a patient with a second tumor of the oropharynx. Strahlentherapie und Onkologie. 191(8). 681–686.

20.

Hecht, Markus, Marlen Haderlein, Luitpold Distel, et al.. (2014). Increased skin and mucosal toxicity in the combination of vemurafenib with radiation therapy. Strahlentherapie und Onkologie. 190(12). 1169–1172. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact